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Effects of consuming different 
doses of red wine on male blood 
pressure
Abstract
Introduction: Moderate consumption of red wine (RW) has been associ-
ated with a decrease in cardiovascular risk due to its phenolic composi-
tion. Purpose: Assessing the effects of consuming different doses of RW 
on the blood pressure (BP) of men during 24 hours after its ingestion. 
Methods: 10 normotensive male subjects (25.1±3.6 years) consumed three 
different doses of RW (250ml, 200ml and 150ml) randomly for three 
weeks; one dose was ingested per week. The BP was measured by using 
the Ambulatory BP Monitoring every 15 minutes during waking, and 
every 30 minutes during the sleep period for 24 hours. Results: There 
was a reduction in mean values  of Systolic Blood Pressure (SBP) from six 
to nine hours of waking period, and the Diastolic Blood Pressure (DBP) 
from nine to 12 hours of sleep compared with BP at rest. Conclusions: 
The moderate RW consumption significantly reduced SBP and DBP in 
men, with a 150ml dose sufficient to reduce and maintain better BP levels.
Keywords: Wine; Blood pressure; Men; Blood Pressure Monitoring, 
Ambulatory. 
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Introduction
Cardiovascular disorders (CVD) account-
ed for 17.5 million deaths worldwide in 20121, 
and in Brazil, approximately 100,000 annual 
deaths are due to heart diseases2, accounting for 
at least 20% of the deaths of the Brazilians over 
30 years of age3. Therefore, these diseases have 
been considered as the main problems concern-
ing national public health, and they are config-
ured as chronic and multifactorial disorders4.
High blood pressure levels have a strong 
impact on the increased risk for CVD5, resulting 
in systemic arterial hypertension. In Brazil, hy-
pertension affects 32.5% (36 million) adults, in 
addition to contributing to 50% of deaths caused 
by CVD6. However, the moderate consumption 
of red wine (RW) has been recommended in epi-
demiological studies7-9 as a means of prevention 
and alternative intervention, since it reduces the 
incidence of cardiovascular events and blood 
pressure (BP) levels.
Moderate RW ingestion increases the ex-
pression and production of nitric oxide (NO), 
which is the main responsible factor for vaso-
dilatation of the arteries, and a great ally in 
the treatment of BP-related problems10, which 
shows an inverse relationship between RW 
consumption and the development of coronary 
artery disease11.
The beneficial effects of RW are derived 
from phenolic compounds (resveratrol, quer-
cetin, gallic, caffeic and tannic acids) found in 
grape12 and alcohol, which in moderate amounts 
enhance cardiovascular protection due to their 
antioxidant properties13. In addition, the RW 
from Vale do São Francisco region in northeast-
ern Brazil has shown differentiated characteris-
tics in its phenolic composition, since it has high 
antioxidant activity when compared with wines 
from different regions worldwide, with high 
levels of epigallocatechin, trans-caffeic acid14 
and cis-resveratrol, a significant factor for the 
wine produced in this region 15,16.
Although the RW effect on blood pressure 
reduction and cardiovascular protection is well 
evidenced, its concentration and dosage might 
influence the effect zone17-19, and there is no con-
sensus in the current literature on the ideal dose 
for daily consumption that shall reduce the BP. 
Therefore, the present study aimed at assessing 
the effects of consuming different doses of RW 
on the BP of adult men from Vale do São Francisco 
during the 24 hours after its ingestion.
Materials and methods
This is a longitudinal quantitative study, 
which assessed the effect of consuming differ-
ent RW doses on the BP of healthy adults in the 
city of Petrolina, state of Pernambuco, north-
eastern Brazil. Such a study was part of an ex-
periment of a larger project entitled ‘The effect 
of red wine, grape peel and grape juice from 
Vale do São Francisco on normotensive and hy-
pertensive humans considering cardiovascular 
aspects, body composition, lipid profile and 
physical performance in weight training’, ap-
proved by the Committee on Ethical Research 
with Humans and Animals (CERHA) of the 
university known as Universidade Federal do Vale 
do São Francisco (UNIVASF) under Protocol no. 
0008/240811.
Ten 18-35-year-old male subjects, students at 
UNIVASF, who were healthy, non-smokers, sed-
entary, with no symptoms of acute diseases and 
who accepted to participate in the study by sign-
ing the Free Informed Consent Form (FICF) were 
assessed. The participants were recruited by using 
print and digital information for four weeks.
Design and experimental protocol
The volunteers were informed about the 
general characteristics of the study, and previ-
ously advised not to perform any type of vig-
orous physical activity and not to ingest alco-
holic drinks during the 24 hours prior to the 
days of data collection. In addition, the subjects 
were advised to avoid drinking caffeine-based 
beverages, not to be on urinary continence at 
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the time of their BP measurement, have a good 
night sleep (minimum of six hours) before col-
lection, and maintain usual activities during 
the study period.
Initially, the body mass (BM) and height 
of the participants were measured for calculat-
ing the body mass index (BMI), as recommend-
ed by the World Health Organization (WHO)20. 
Then, the participants consumed different dos-
es of RW with ambulatory blood pressure mon-
itoring (ABPM) to verify BP behavior during 
a 24-hour period according to the V Brazilian 
Guidelines of ABPM21. All measurements were 
carried out by a single evaluator with experi-
ence in the procedures.
The BM was measured by using an an-
thropometric mechanical scale, Balmak (model 
104A) with an accuracy of 0.1 kg; and height 
with the stadiometer of the scale itself with an 
accuracy of 0.1 cm. The BMI was determined 
by the body mass/height ratio2; the BM was ex-
pressed in kilograms and the height in meters.
Each participant consumed three differ-
ent doses of RW (250ml, 200ml and 150ml) in a 
total period of three weeks; one dose per week. 
The order of the doses was at random for each 
participant, only maintaining the standard of 
the day, time of consumption and installation 
of the device to verify the BP. Fine dry RW was 
consumed with an approximate temperature 
between 16 and 18ºC of the Shiraz grape, with 
an alcoholic graduation of 13% and produced in 
Vale do São Francisco during the harvest of 2010.
The resting BP was measured by using the 
Meditech ABPM device (model ABPM-04), with 
the participants seated on a chair and at rest for 
10 minutes prior to data collection. The evalua-
tion was carried out at the same place and with 
the left arm being raised to the height of the 
sternum midpoint and supported on a table.
BP monitoring was performed by using 
ABPM, which measured the BP of the volun-
teers every 15 minutes during the waking pe-
riod and every 30 minutes during the sleep pe-
riod for 24 hours from the time the participant 
had ingested RW.
Statistical analysis
Descriptive statistics was used with mean 
and standard deviation. All the variables were 
in absolute variation (Δ = difference between the 
periods and rest). After assessing and finding 
the normality of data distribution with Shapiro-
Wilk test, the two-way ANOVA for repeated 
measures was used to verify the main effects of 
the interaction ‘time’ (Rest, 3h, 6h, 9h, 12h and 
15h)*, condition (150ml, 200ml and 250ml) and 
the main effects on time under the different con-
ditions. The values  of ‘F-ratio’, degrees of free-
dom and ‘p’ were reported.
The two-way ANOVA for repeated mea-
surements was also used for intra-individual 
comparison between the total means of the 15h 
ABPM analysis in the three conditions (150ml, 
200ml and 250ml). The ‘F-ratio’ values, freedom 
degrees and ‘p’ were reported. Bonferroni post 
hoc was adopted to identify the difference pairs. 
The significance level was set at p <0.05, and the 
IBM® SPSS® Statistics software version 22.0.0.0 
was used for data analysis.
Results
The participants consisted of 10 men, mean 
age of 25.1 ± 3.6 years, a body mass of 75.4 ± 6.2 
kg, height of 1.73 ± 3.4 meters and BMI of 24.9 
± 1.8 kg/m². There were significant reductions 
with the consumption of different RW doses, 
mainly in the mean values  of both, the SBP dur-
ing the waking period and the DBP in the sleep 
period, compared to the resting BP of the vol-
unteers.
Figure 1 shows the absolute variation 
(ΔmmHg) of SBP (1A) and DBP (1B) during the 
total period of 15h of ABPM in the three condi-
tions. There was a main time effect for SBP [F(5,45)= 
29,840; p<0,001; η2= 0,76] and DBP [F(5,45)= 35,615; 
p<0,001; η2= 0,79], as well as time*condition in-
teraction for SBP [F(10,90)= 2,612; p<0,01; η
2= 0,22] 
and DBP [F(10,90)= 2,558; p<0,05; η
2= 0,20].
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Table 1 shows the mean ± standard devia-
tion of SBP reduction (mmHg) during the total 
period of the intra-individual ABPM at the dif-
ferent doses, in addition to the interaction val-
ues among the conditions.
Table 1 shows a greater reduction of the 
SBP clinical values  (mmHg) in the interval from 
six to nine hours of waking period after RW 
ingestion, with reductions of up to -20.3 ± 12.4 
mmHg for 250 ml, -18.6 ± 17.2 mmHg for 200 ml 
and -31.7 ± 12.8 mmHg for 150 ml.
Figure 2 shows the intra-individual abso-
lute variation of SBP (ΔmmHg) during the total 
period of 15 h of ABPM in the three conditions 
(150 ml, 200 ml and 250 ml of RW).
At the interval of the first nine hours cor-
responding to the waking period it was seen 
that the dose of 150 ml of RW was able to pro-
vide greater reductions of the SBP (ΔmmHg) in 
62.5% of the volunteers, followed by the dose of 
200 ml in 37, 5% of the participants. It is worth 
mentioning that the dose of 250 ml also reduced 
the SBP values  (ΔmmHg) in such a period, but 
with less significance.
Table 2 shows the mean ± standard devia-
tion of DBP reduction (mmHg) in the total pe-
riod of intra-individual ABPM in the different 
doses, besides the interaction values among the 
conditions.
During the sleep period, a greater reduc-
tion was seen in the interval from 9 to 12 hours 
after RW ingestion, with reductions of up to 
-20.8 ± 11.0 mmHg for 250 ml, -19.3 ± 5.0 mmHg 
for 200 ml and -17.7 ± 15.0 for 150 ml.
Figure 1
Absolute variation (Δ mmHg) of SBP (A) and DBP (B) 
during the total ABPM period of 15 h under the three 
conditions, Petrolina-PE, 2015. *p<0.05 in relation 
to REST for the dose of 150 ml ; #p <0.05 in relation 
to REST for 200 ml and 250 ml; †p <0.05 when 
compared to 150 ml with 250 ml; ‡ p <0.05 when 
compared to 150 ml with 200 ml; $p <0.05 in relation 
to REST for 250 ml.
Source: Authors.
Table 1: Mean±SD of SBP reduction (mmHg) during the total intravoluntary ABPM period in the 
different doses (n=10), Petrolina-PE, 2015
150 ml 200 ml 250 ml ANOVA
Participant 1 -31.7±12.8* -13.4±11.2 -12.7±17.6 F(2,8)= 10.453 P<0.01 η
2= 0.72
Participant 2 -17.6±9.2 -13.3±10.5 -15.2±10.4 F(2,8)= 1.838 P=0.22 η
2= 0.31
Participant 3 -7.3±9.6 -6.5±13.0 -9.4±5.9 F(2,8)= 0.327 P=0.73 η
2= 0.07
Participant 4 -12.1±13.4* 31.5±8.8 -2.7±8.6 F(2,8)= 74.529 P<0.001 η
2= 0.95
Participant 5 -26.5±10.1† -18.6±17.2 -11.4±11.2 F(2,8)= 6.987 P<0.05 η
2= 0.63
Participant 6 -5.1±14.8 -4.8±11.7 -2.4±10.5 F(2,8)= 0.429 P=0.66 η
2= 0.09
Participant 7 -8.5±8.1† -11.4±6.4† 6.8±5.0 F(2,8)= 25.716 P<0.01 η
2= 0.86
Participant 8 -27.7±15.3 -12.9±4.9 -20.3±12.4 F(2,8)= 3.314 P=0.08 η
2= 0.45
Participant 9 -12.5±9.0 -9.2±7.5 -9.8±8.4 F(2,8)= 4.402 P<0.05 η
2= 0.53
Participant 10 -18.5±12.1*† -2.5±7.7† 4.0±7.6 F(2,8)= 33.664 P<0.001 η
2= 0.89
*p<0.05 in relation to the dose of 200 ml; †p<0.05 in relation to the dose of 250 ml.
Source: Authors.
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Figure 2: Intra-individual absolute variation of SBP (Δ mmHg) during the total ABPM period of 
15h under the three conditions, Petrolina-PE, 2015.
Source: Authors.
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Figure 3 shows the intra-individual abso-
lute variation of DBP (ΔmmHg) during the total 
period of 15h of ABPM in the three conditions.
Figure 3 shows that the dose of 150 ml of 
RW caused greater reductions in DBP (Δ mmHg) 
in 50% of the volunteers, followed by doses of 
200 ml in 32.5% and 250 ml in 17.5 % of the vol-
unteers.
Discussion
The present study showed a significant 
reduction of BP for some dosages, with a sig-
nificant clinical reduction of up to -31.7 ± 12.8 
mmHg in SBP and up to -20.8 ± 11.0 mmHg for 
250 ml of RW compared with BP at rest. In a 
similar study22 it was shown that the ingestion 
of 100 ml of RW 30 minutes before an aerobic 
exercise session provided a higher post-exercise 
SBP of up to -10.7 ± 3.5 mmHg and in the DBP of 
- 5.6 ± 4.9 mmHg in relation to exercise sessions 
without prior RW ingestion.
According to the results of this research, 
when comparing the consumption of different 
doses of wine in relation to BP reduction, there 
was an expressive decrease of SBP and DBP in 
the first three to six hours following the dose 
of 200 ml and, mainly with the dose of 150 ml. 
Barden et al.23, when monitoring BP for 24 hours 
in normotensive men, found a reduction in SBP 
and DBP in the first four hours after the inges-
tion of a single dose of alcoholic RW (375 ml).
Huang et al.24 studied eighty healthy sub-
jects who were asked to consume water (100 ml), 
RW (100 ml), beer (250 ml) or vodka (30 ml) daily 
for three weeks. The authors found an increase 
in NO plasma in the young subjects who con-
sumed 100 ml/day of RW, which was not seen 
when concerning the consumption of equivalent 
amounts of alcohol, such as beer or vodka; NO 
is a substance responsible for the vasodilata-
tion of the arteries, besides being a great ally in 
Table 2: Mean±DP of DBP reduction (mmHg) during the total intravoluntary ABPM period in the 
different doses (n=10), Petrolina-PE, 2015
150 ml 200 ml 250 ml ANOVA
Participant 1 -7.7±11.2 -11.9±12.9 -11.4±14.7 F(2,8)= 0.184 P=0.83 η
2= 0.04
Participant 2 -11.5±5.4 -3.6±9.0† -12.1±10.1 F(2,8)= 4.254 P<0.05 η
2= 0.52
Participant 3 -15.9±9.6* -3.4±9.5 -3.9±3.8 F(2,8)= 10.796 P<0.01 η
2= 0.73
Participant 4 -10.1±7.9* 10.7±4.0 -11.6±7.0 F(2,8)= 33.642 P<0.001 η
2= 0.89
Participant 5 -11.1±8.6 -10.0±17.0 -11.7±10.6 F(2,8)= 0.900 P=0.91 η
2= 0.02
Participant 6 -10.1±11.4 -5.5±10.4 -3.0±6.8 F(2,8)= 3.385 P=0.08 η
2= 0.46
Participant 7 -16.0±10.1 -12.8±4.6 -11.8±6.7 F(2,8)= 1.125 P=0.34 η
2= 0.23
Participant 8 -17.7±15.0 -19.3±5.0 -20.8±11.0 F(2,8)= 0.174 P=0.84 η
2= 0.04
Participant 9 -12.7±7.1* -1.7±4.7† -11.9±7.3 F(2,8)= 37.530 P<0.001 η
2= 0.90
Participant 10 -10.2±6.7* -2.0±5.4† -14.1±8.5 F(2,8)= 15.636 P<0.01 η
2= 0.79
*p<0.05 in relation to the dose of 200 ml; †p<0.05 in relation to the dose of 250 ml.
Source: Authors.
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Figure 3: Intra-individual absolute variation of SBP (Δ mmHg) during the total ABPM period of 
15h under the three conditions, Petrolina-PE, 2015. 
Source: Authors.
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the treatment of problems associated with high 
blood pressure levels.
The research by Krnic et al.25 compared the 
acute effects of RW, vodka, beer (0.32 g ethanol 
/ body weight-kg) and water as a control of the 
increase of oxidative stress and oxygen-induced 
arterial stiffness in healthy men. The results 
showed that alcoholic beverages provided simi-
lar protection against increased arterial stiff-
ness, but only RW provided protection against 
oxidative stress. However, Chiva-Blanch et al.8, 
after four weeks of interventions with RW in-
gestion, non-alchoolic red wine (NARW) and 
Vodka-Gin in a cross-sectional study with sev-
enty-three 55-75-year-old men with a high car-
diovascular risk, showed that NARW decreased 
SBP and DBP while increasing NO plasma con-
centration. RW tended to have effects similar to 
those of NARW, but BP changes were not sig-
nificant, and Gin had no effect.
O’keefe et al.9 emphasize that among sev-
eral alcoholic beverages, RW is usually associ-
ated with better health outcomes, especially 
when considering cardiovascular issues. This is 
probably due to its unique matrix of non-alco-
holic components, which are known as potent 
antioxidants26 and have relevant biochemical 
and pharmacological effects when consumed in 
moderation, as part of a balanced diet and main-
ly by people who do not have a contraindication 
to the consumption of alcoholic beverages7. 
Considering the beneficial effects of alco-
hol consumption, Ronksleyet et al.11 advocate a 
protective association of alcohol seen in several 
populations of female and male patients, as well 
as a specific association: moderate drinking (up 
to 1 drink or 12.5 g of alcohol per day for wom-
en, and 2 drinks or 25 g of alcohol per day for 
men) is associated with lower rates of cardiovas-
cular disease.
Among other alcoholic beverages, RW 
is widely studied and applied in diets due to 
its effectiveness in cardioprotective function. 
Tresserra-Rimbau et al.27 in a cross-sectional 
study highlighted that wine is considered a key 
component in the traditional Mediterranean 
diet, and that different designs have suggested 
that the higher health benefits of moderate RW 
consumption may be related to its higher con-
tent of polyphenols compared with other alco-
holic beverages. Sabadashka et al.10 also found 
that the natural polyphenol complex might at-
tenuate oxidative-nitrative stress caused by ion-
izing radiation.
According to the systematic review by 
Barbosa and Fernandes28, most studies empha-
size the effects of resveratrol on cardiovascular 
health in individuals affected by CVD and in 
animals with atherogenic diet, such as signifi-
cant improvement of lipid profile parameters, 
attenuation of oxidative stress and inflamma-
tion, prevention of endothelial dysfunction and 
SBP reduction. However, dosage, time and form 
of ingestion considered ideal require discus-
sions, not yet clearly defined in the literature.
Polyphenols are found in various forms, 
such as quercetin and resveratrol, and in differ-
ent kinds of food. Habauzit and Morand29 em-
phasized the consumption of food rich in poly-
phenols (fruits and fruit juice, tea, wine, cocoa, 
among others) and the protective effect of the 
compounds on CVD, which shows a reduction of 
SBP (-7 ± 2 mmHg ) and DBP (-5 ± 2 mmHg) in 
hypertensive patients Stage 1 after the treatment 
with quercetin. Another meta-analysis30 found 
associations of flavonol ingestion with stroke 
incidence, in addition to finding in two placebo-
controlled clinical trials that quercetin increased 
NO plasma concentration by 35% and, in hyper-
tensive patients, reduced SBP in 7 mmHg.
The reduction of clinically significant BP 
provided by RW consumption at some doses 
seen in the present study can be explained by 
the sample size, which is still insufficient so that 
the difference found is statistically higher.
This study has some limitations, such as 
the non-use of a control group, since its real 
purpose was to compare the different doses of 
RW consumption in the reduction of BP in view 
of the necessity of a consensus of an ideal dos-
age. The participants were normotensive, which 
restricted the results for healthy individuals. In 
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addition, the sample was small for more com-
prehensive results in relation to the population 
assessed; in fact, it is difficult to recruit and se-
lect participants for longitudinal studies with 
methodological rigor and usual restrictions.
Conclusion
Moderate RW consumption in Vale do 
São Francisco reduced SBP and DBP in acutely 
healthy adult men, taking into account the mean 
BP values  after the consumption of RW near or 
below the resting values. It is worth mentioning 
that a dose of 150 ml is enough to reduce and 
maintain better blood pressure levels, possibly 
due to the moderate amount of alcohol com-
pared with the other doses.
It is recommended that further research 
is carried out in order to analyze the effects of 
RW doses on different populations for obtaining 
more reliable and comprehensive results.
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